135 related articles for article (PubMed ID: 9582317)
41. Natural genetic variations in bovine leukemia virus envelope gene: possible effects of selection and escape.
Zhao X; Buehring GC
Virology; 2007 Sep; 366(1):150-65. PubMed ID: 17498765
[TBL] [Abstract][Full Text] [Related]
42. Discordance between bovine leukemia virus tax immortalization in vitro and oncogenicity in vivo.
Twizere JC; Kerkhofs P; Burny A; Portetelle D; Kettmann R; Willems L
J Virol; 2000 Nov; 74(21):9895-902. PubMed ID: 11024116
[TBL] [Abstract][Full Text] [Related]
43. A mutant form of the tax protein of bovine leukemia virus (BLV), with enhanced transactivation activity, increases expression and propagation of BLV in vitro but not in vivo.
Tajima S; Takahashi M; Takeshima SN; Konnai S; Yin SA; Watarai S; Tanaka Y; Onuma M; Okada K; Aida Y
J Virol; 2003 Feb; 77(3):1894-903. PubMed ID: 12525624
[TBL] [Abstract][Full Text] [Related]
44. An antibody that blocks human T-cell leukemia virus type 1 six-helix-bundle formation in vitro identified by a novel assay for inhibitors of envelope function.
Mirsaliotis A; Nurkiyanova K; Lamb D; Kuo CS; Brighty DW
J Gen Virol; 2007 Feb; 88(Pt 2):660-669. PubMed ID: 17251585
[TBL] [Abstract][Full Text] [Related]
45. Functional importance of the coiled-coil of the Ebola virus glycoprotein.
Watanabe S; Takada A; Watanabe T; Ito H; Kida H; Kawaoka Y
J Virol; 2000 Nov; 74(21):10194-201. PubMed ID: 11024148
[TBL] [Abstract][Full Text] [Related]
46. The region between amino acids 245 and 265 of the bovine leukemia virus (BLV) tax protein restricts transactivation not only via the BLV enhancer but also via other retrovirus enhancers.
Tajima S; Aida Y
J Virol; 2000 Dec; 74(23):10939-49. PubMed ID: 11069988
[TBL] [Abstract][Full Text] [Related]
47. Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection.
Portetelle D; Limbach K; Burny A; Mammerickx M; Desmettre P; Riviere M; Zavada J; Paoletti E
Vaccine; 1991 Mar; 9(3):194-200. PubMed ID: 1645899
[TBL] [Abstract][Full Text] [Related]
48. Functional implications of the human T-lymphotropic virus type 1 transmembrane glycoprotein helical hairpin structure.
Maerz AL; Center RJ; Kemp BE; Kobe B; Poumbourios P
J Virol; 2000 Jul; 74(14):6614-21. PubMed ID: 10864675
[TBL] [Abstract][Full Text] [Related]
49. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
Maerz AL; Drummer HE; Wilson KA; Poumbourios P
J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
[TBL] [Abstract][Full Text] [Related]
50. Enhancement of bovine leukemia virus-induced syncytia formation by di- and tripeptides.
Vonèche V; Callebaut I; Lambrecht B; Brasseur R; Burny A; Portetelle D
Virology; 1993 Jan; 192(1):307-11. PubMed ID: 8390756
[TBL] [Abstract][Full Text] [Related]
51. The conserved glycine-rich segment linking the N-terminal fusion peptide to the coiled coil of human T-cell leukemia virus type 1 transmembrane glycoprotein gp21 is a determinant of membrane fusion function.
Wilson KA; Bär S; Maerz AL; Alizon M; Poumbourios P
J Virol; 2005 Apr; 79(7):4533-9. PubMed ID: 15767455
[TBL] [Abstract][Full Text] [Related]
52. The critical N-linked glycan of murine leukemia virus envelope protein promotes both folding of the C-terminal domains of the precursor polyprotein and stability of the postcleavage envelope complex.
Li Z; Pinter A; Kayman SC
J Virol; 1997 Sep; 71(9):7012-9. PubMed ID: 9261431
[TBL] [Abstract][Full Text] [Related]
53. Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide.
Wu BW; Lu J; Gallaher TK; Anderson WF; Cannon PM
Virology; 2000 Mar; 269(1):7-17. PubMed ID: 10725193
[TBL] [Abstract][Full Text] [Related]
54. Mutational analysis of bovine leukemia virus Rex: identification of a dominant-negative inhibitor.
Choi EA; Hope TJ
J Virol; 2005 Jun; 79(11):7172-81. PubMed ID: 15890956
[TBL] [Abstract][Full Text] [Related]
55. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.
Rein A; Mirro J; Haynes JG; Ernst SM; Nagashima K
J Virol; 1994 Mar; 68(3):1773-81. PubMed ID: 8107239
[TBL] [Abstract][Full Text] [Related]
56. Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein.
Lavillette D; Ruggieri A; Boson B; Maurice M; Cosset FL
J Virol; 2002 Oct; 76(19):9673-85. PubMed ID: 12208946
[TBL] [Abstract][Full Text] [Related]
57. Lack of LTR and ENV genetic variation during bovine leukemia virus-induced leukemogenesis.
Willems L; Kerkhofs P; Burny A; Mammerickx M; Kettmann R
Virology; 1995 Jan; 206(1):769-72. PubMed ID: 7831840
[TBL] [Abstract][Full Text] [Related]
58. Sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins.
Mamoun RZ; Morisson M; Rebeyrotte N; Busetta B; Couez D; Kettmann R; Hospital M; Guillemain B
J Virol; 1990 Sep; 64(9):4180-8. PubMed ID: 1696635
[TBL] [Abstract][Full Text] [Related]
59. An increase in disease latency is associated with a host-dependent selection for recombinant murine leukemia viruses with substitutions in the p15E (TM) gene.
Thomas CY; Coppola MA; Nuckols JD; Lawrenz-Smith SC; Massey AC
J Virol; 1993 Jan; 67(1):294-304. PubMed ID: 8380077
[TBL] [Abstract][Full Text] [Related]
60. The "putative" leucine zipper region of murine leukemia virus transmembrane protein (P15e) is essential for viral infectivity.
Ramsdale EE; Kingsman SM; Kingsman AJ
Virology; 1996 Jun; 220(1):100-8. PubMed ID: 8659102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
